SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
193 hedge funds and large institutions have $1.21B invested in Sage Therapeutics in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 83 increasing their positions, 44 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
46% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 59
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
52% less capital invested
Capital invested by funds: $2.54B → $1.21B (-$1.33B)
Holders
193
Holding in Top 10
1
Calls
$19.5M
Puts
$8.57M
Top Buyers
| 1 | +$106M | |
| 2 | +$42.8M | |
| 3 | +$15.2M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$10.9M |
| 5 |
Morgan Stanley
New York
|
+$10.5M |
Top Sellers
| 1 | -$38.9M | |
| 2 | -$23.5M | |
| 3 | -$22.5M | |
| 4 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$16.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$14.2M |